Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 1998, p. 5981-5991, Vol. 18, No. 10
Department of Molecular Genetics and
Microbiology, State University of New York, Stony Brook, New York
11794-5222
Received 12 May 1998/Returned for modification 30 June
1998/Accepted 30 June 1998
G-protein-coupled receptors (GPCRs) transduce the signals for a
wide range of hormonal and sensory stimuli by activating a heterotrimeric guanine nucleotide-binding protein (G protein). The
analysis of loss-of-function and constitutively active receptor mutants has helped to reveal the functional properties of GPCRs and
their role in human diseases. Here we describe the identification of a
new class of mutants, dominant-negative mutants, for the yeast
G-protein-coupled
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Dominant-Negative Mutations in the G-Protein-Coupled
-Factor
Receptor Map to the Extracellular Ends of the Transmembrane
Segments

-factor receptor (Ste2p). Sixteen
dominant-negative receptor mutants were isolated based on their ability
to inhibit the response to mating pheromone in cells that also express
wild-type receptors. Detailed analysis of two of the strongest mutant
receptors showed that, unlike other GPCR interfering mutants, they were properly localized at the plasma membrane and did not alter the stability or localization of wild-type receptors. Furthermore, their
dominant-negative effect was inversely proportional to the relative
amount of wild-type receptors and was reversed by overexpressing the
G-protein subunits, suggesting that these mutants compete with the
wild-type receptors for the G protein. Interestingly, the
dominant-negative mutations are all located at the extracellular ends
of the transmembrane segments, defining a novel region of the
receptor that is important for receptor signaling. Altogether, our
results identify residues of the
-factor receptor specifically involved in ligand binding and receptor activation and define a new
mechanism by which GPCRs can be inactivated that has important implications for the evaluation of receptor mutations in other G-protein-coupled receptors.
*
Corresponding author. Mailing address: Department of
Molecular Genetics and Microbiology, State University of New York,
Stony Brook, NY 11794-5222. Phone: (516) 632-8715. Fax: (516) 632-9797. E-mail: konopka{at}asterix.bio.sunysb.edu.
Present address: CuraGen Corporation, New Haven, CT 06511.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|